The subsidiary, known as Areteia Therapeutics Inc., will take over the development of Knopp’s drug candidate, dexpramipexole, used to treat eosinophilic asthma.
The primary purpose of the site is to provide Real Estate & Mortgage information as it relates to today’s business environment. It can also be used to answer related question you might have about buying, selling, or financing real estate.
The subsidiary, known as Areteia Therapeutics Inc., will take over the development of Knopp’s drug candidate, dexpramipexole, used to treat eosinophilic asthma.
